PCM
Prelude Capital Management Portfolio holdings
AUM
$1.02B
1-Year Return
30.93%
This Quarter Return
+0.76%
1 Year Return
+30.93%
3 Year Return
+112.01%
5 Year Return
+170.21%
10 Year Return
+650.33%
AUM
$1.11B
AUM Growth
-$95.3M
(-7.9%)
Cap. Flow
-$77.7M
Cap. Flow
% of AUM
-7.03%
Top 10 Holdings %
Top 10 Hldgs %
14.67%
Holding
1,390
New
358
Increased
306
Reduced
238
Closed
366
Top Buys
| 1 |
NEWR
New Relic, Inc.
NEWR
|
+$11.2M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$10.5M |
| 3 |
Alibaba
BABA
|
+$9.9M |
| 4 |
KE Holdings
BEKE
|
+$7.95M |
| 5 |
Trip.com Group
TCOM
|
+$7M |
Top Sells
| 1 |
Green Brick Partners
GRBK
|
+$48.6M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$36.4M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$35.9M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$12.8M |
| 5 |
JD.com
JD
|
+$11.3M |
Sector Composition
| 1 | Technology | 20.19% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Industrials | 10.74% |
| 5 | Energy | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Perimeter Solutions
PRM
$3.31B
| $47.9K | ﹤0.01% |
10,542
-5,291
| -33% | -$24K |
|
|
GRCL
902
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $47K | ﹤0.01% |
+16,327
| New | +$47K |
|
903
Relmada Therapeutics
RLMD
$50.5M
| $46.9K | ﹤0.01% |
15,642
-2,958
| -16% | -$8.87K |
|
904
Telos
TLS
$463M
| $46.7K | ﹤0.01% |
19,536
-5,294
| -21% | -$12.7K |
|
|
KNTE
905
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $45.2K | ﹤0.01% |
32,309
+3,555
| +12% | +$4.98K |
|
906
Nuvation Bio
NUVB
$1.14B
| $44.1K | ﹤0.01% |
32,932
-32,572
| -50% | -$43.6K |
|
907
Porch Group
PRCH
$1.94B
| $43K | ﹤0.01% |
53,520
-4,653
| -8% | -$3.73K |
|
908
Cardio Diagnostics
CDIO
$6.82M
| $41.1K | ﹤0.01% |
4,033
+366
| +10% | +$3.73K |
|
909
Advantage Solutions
ADV
$613M
| $39K | ﹤0.01% |
+13,728
| New | +$39K |
|
|
DZSI
910
DELISTED
DZS Inc. Common Stock
DZSI
| $38K | ﹤0.01% |
+18,100
| New | +$38K |
|
911
DURECT Corp
DRRX
$60.2M
| $37.6K | ﹤0.01% |
15,081
+3,793
| +34% | +$9.45K |
|
912
Rimini Street
RMNI
$428M
| $36.3K | ﹤0.01% |
16,512
-6,778
| -29% | -$14.9K |
|
913
Solid Power
SLDP
$682M
| $35.4K | ﹤0.01% |
17,500
-9,300
| -35% | -$18.8K |
|
914
Altimmune
ALT
$327M
| $32.8K | ﹤0.01% |
+12,600
| New | +$32.8K |
|
|
ZH
915
Zhihu
ZH
$445M
| $31.6K | ﹤0.01% |
+5,064
| New | +$31.6K |
|
916
Surrozen
SRZN
$100M
| $30.2K | ﹤0.01% |
4,113
| – | – |
|
917
Erasca
ERAS
$454M
| $28.2K | ﹤0.01% |
14,300
| – | – |
|
|
CVIIW
918
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
| $25.9K | ﹤0.01% |
84,235
-113,775
| -57% | -$35K |
|
919
Ares Acquisition Corp II Redeemable Warrants
AACT.WS
| $23.6K | ﹤0.01% |
+100,590
| New | +$23.6K |
|
|
CANO
920
DELISTED
Cano Health, Inc.
CANO
| $21.5K | ﹤0.01% |
846
+581
| +219% | +$14.7K |
|
921
Nkarta
NKTX
$145M
| $20.8K | ﹤0.01% |
14,929
-700
| -4% | -$973 |
|
922
Pyxis Oncology
PYXS
$113M
| $20.6K | ﹤0.01% |
10,352
| – | – |
|
923
BioAtla
BCAB
$39.2M
| $18.8K | ﹤0.01% |
11,083
-4,917
| -31% | -$8.36K |
|
924
Algoma Steel Group Warrant
ASTLW
$6.41M
| $15K | ﹤0.01% |
12,313
| – | – |
|
|
NBSE
925
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $13.5K | ﹤0.01% |
15,550
| – | – |
|